[Form 4] Axos Financial, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Candace L. Thiele, EVP & Chief Administrative Officer of Axos Financial, reported a sale of 700 shares of Axos Financial common stock on 09/03/2025 at an average price of $90.135 per share. After the sale she beneficially owned 23 shares directly and 167 shares indirectly (via a 401(k) plan), for a total of 190 shares disclosed on this Form 4. The filing was signed by an authorized filer on her behalf.

Positive

• None.

Negative

• Insider sale of 700 shares at $90.135 reduces direct ownership to 23 shares, which could be viewed as reduced insider stake

Insights

Securities Analyst

TL;DR: Insider sale of 700 AX shares at $90.135 reduces direct holdings to 23 shares; transaction is routine disclosure.

The filing documents a single open-market sale by a named executive on 09/03/2025. The sale size (700 shares) is modest relative to typical institutional volumes and leaves the reporting person with 23 direct shares and 167 indirectly held shares through a 401(k) plan. There is no indication of derivative transactions or other concurrent trades in this Form 4. From a market-impact perspective, this appears to be a routine insider liquidity event rather than a material shift in ownership.

Corporate Governance Expert

TL;DR: The Form 4 accurately discloses a single sale and shows compliance with Section 16 reporting requirements.

The report shows timely disclosure of an officer-level sale and specifies ownership form (direct and indirect), which satisfies standard SEC transparency expectations. The signature by an authorized representative is included. There is no information here about a Rule 10b5-1 plan or any amendments, so no defensive trading plan is claimed in this filing. Documentation is complete for the reported non-derivative transaction.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

THIELE CANDACE L

(Last) (First) (Middle)

9205 WEST RUSSELL ROAD

SUITE 400

(Street)

LAS VEGAS NV 89148

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Axos Financial, Inc. [ AX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			EVP, Chief Administrative Offi

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/03/2025		S		700	D	$90.135	23	D
Common Stock								167	I	401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	By: Derrick Walsh For: Candace Thiele	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Candace Thiele report on Form 4 for AX?

She reported a sale of 700 shares of Axos Financial common stock on 09/03/2025 at an average price of $90.135 per share.

How many AX shares does Candace Thiele beneficially own after the reported transaction?

The Form 4 shows she beneficially owned 23 shares directly and 167 shares indirectly (via a 401(k) plan), totaling 190 shares following the sale.

Was the Form 4 filed jointly or by a single reporting person for AX?

The filing indicates the form was filed by one reporting person.

Does the Form 4 report any derivative transactions or a 10b5-1 plan for this sale?

No derivative transactions are reported and the form does not indicate the sale was made pursuant to a Rule 10b5-1 plan.

Who signed the Form 4 on behalf of the reporting person?

The Form 4 was signed by Derrick Walsh on behalf of Candace Thiele on 09/03/2025.